Mohammed F Alotaibi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Angiotensin Converting Enzyme

Oxidative Stress

Top Venues

Drug design, development and therapy

Pharmaceuticals (Basel, Switzerland)

King Saud University

University of Liverpool (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King Saud University Dec 01 2013

Saudi Arabia

Associate Professor :: Physiology

Education History

University of Liverpool Oct 01 2010 - Mar 04 2013

United Kingdom

PHD :: Physiology

Publications

Ahmed M Atwa, Omnia A M Abd El-Ghafar, Emad H M Hassanein, Somya E Mahdi, Ghadir A Sayed, Reem S Alruhaimi, Haifa A Alqhtani, Mohammed F Alotaibi, Ayman Moawad Mahmoud
Candesartan Attenuates Cisplatin-Induced Lung Injury by Modulating Oxidative Stress, Inflammation, and TLR-4/NF-κB, JAK1/STAT3, and Nrf2/HO-1 Signaling. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Mohammed F Alotaibi, Fakhria Al-Joufi, Howida S Abou Seif, Mohammed A Alzoghaibi, Laiche Djouhri, Ahmad F Ahmeda, Ayman Moawad Mahmoud
Umbelliferone Inhibits Spermatogenic Defects and Testicular Injury in Lead-Intoxicated Rats by Suppressing Oxidative Stress and Inflammation, and Improving Nrf2/HO-1 Signaling. Drug design, development and therapy 14 (2020)